Klaus Urbahns, Michael Härter, Markus Albers, Delf Schmidt, Beatrix Stelte-Ludwig, Ulf Brüggemeier, Andrea Vaupel, Jörg Keldenich, Klemens Lustig, Hideki Tsujishita, Christoph Gerdes
Index: Bioorg. Med. Chem. Lett. 17(22) , 6151-4, (2007)
Full Text: HTML
Vitronectin receptor (alpha(V)beta(3)) antagonists have been implicated as a possible new treatment of restenosis following balloon angioplasty. In this work we investigate a series of novel arginine mimetic scaffolds leading to new insight of the alpha(V)beta(3)/ligand interaction. Squaric acid amide 10 is a subnanomolar alpha(V)beta(3) antagonist with improved potency on human smooth muscle cell migration.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Dibutyl squarate
CAS:2892-62-8 |
C12H18O4 |
|
Adjunctive trichloroacetic acid therapy enhances squaric aci...
2012-10-01 [Journal. of. Drugs in. Dermatology. 11(10) , 1228-30, (2012)] |
|
Chronic delayed-type hypersensitivity reaction as a means to...
2004-03-01 [Clin. Exp. Immunol. 135(3) , 398-408, (2004)] |
|
Immunotherapy for childhood warts.
2009-07-01 [Pediatr. Ann. 38(7) , 373-9, (2009)] |
|
Determination of in vivo dose response and allergen-specific...
2008-01-01 [Dermatitis 19(2) , 95-9, (2008)] |
|
Treatment of alopecia areata in children.
2009-07-01 [Pediatr. Ann. 38(7) , 388-95, (2009)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2026 ChemSrc All Rights Reserved
